Tryptamine’s phase 1b study of IV-infused psilocin meets all objectives Lead asset TRP-8803 found safe at low, mid and upper dose levels Planning underway to advance TRP-8803 in phase II trials ...

In the field of health, the development of artificial intelligence (AI) may mean major breakthroughs in personalizing diagnoses and treatments, but there is a need to promote bias-free AI with a more ...